WPD Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:8SV1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24Sell€2,136Caelum Finance Ltd, Asset Management ArmCompany632,000€0.0034
07 Nov 24Sell€3Caelum Finance Ltd, Asset Management ArmCompany1,000€0.0033
03 Oct 24Sell€3Caelum Finance Ltd, Asset Management ArmCompany1,000€0.0034
30 Sep 24Sell€3Caelum Finance Ltd, Asset Management ArmCompany1,000€0.0033
19 Sep 24Sell€3Caelum Finance Ltd, Asset Management ArmCompany1,000€0.0033
10 Sep 24Sell€1,214Caelum Finance Ltd, Asset Management ArmCompany364,000€0.0033
27 Aug 24Sell€3,989Caelum Finance Ltd, Asset Management ArmCompany1,200,000€0.0033

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 8SV1?
Owner TypeNumber of SharesOwnership Percentage
Private Companies12,422,16211%
Individual Insiders31,756,30828%
General Public69,259,77461.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 5 shareholders own 38.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.6%
Waldemar Priebe
31,300,530€1.1m0%no data
10.7%
Triple G Ventures, Llc
12,083,522€406.4k0%no data
0.4%
Peter Novak
453,778€15.3k0%no data
0.3%
Plus Holdings, LLC
338,640€11.4k0%no data
0.0018%
Teresa Rzepczyk
2,000€67.20%no data